Detailed map of the developing human brain opens new pathways for Parkinson's treatment

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...

Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial ...

Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 ...
EurekAlert!

Scientists build detailed map of the developing human brain, opening new pathways for Parkinson’s treatment

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...
News-Medical.Net on MSN

Breakthrough research offers first targeted treatment option for NRAS-mutant melanoma

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...